<VariationArchive RecordType="classified" VariationID="1343458" VariationName="NM_000263.4(NAGLU):c.410_413del (p.Thr137fs)" VariationType="Deletion" Accession="VCV001343458" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-03-12" MostRecentSubmission="2022-03-12">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1335157" VariationID="1343458">
      <GeneList>
        <Gene Symbol="NAGLU" FullName="N-acetyl-alpha-glucosaminidase" GeneID="4669" HGNC_ID="HGNC:7632" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="42536241" stop="42544449" display_start="42536241" display_stop="42544449" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="40687950" stop="40696466" display_start="40687950" display_stop="40696466" Strand="+" />
          </Location>
          <OMIM>609701</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000263.4(NAGLU):c.410_413del (p.Thr137fs)</Name>
      <CanonicalSPDI>NC_000017.11:42537420:GCACGCA:GCA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="42537421" stop="42537424" display_start="42537421" display_stop="42537424" variantLength="4" positionVCF="42537420" referenceAlleleVCF="TGCAC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="40689439" stop="40689442" display_start="40689439" display_stop="40689442" variantLength="4" positionVCF="40689438" referenceAlleleVCF="TGCAC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>T137fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.40689442_40689445del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.40689442_40689445del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.42537424_42537427del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.42537424_42537427del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011552.1" sequenceAccession="NG_011552" sequenceVersion="1" change="g.6492_6495del">
            <Expression>NG_011552.1:g.6492_6495del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000263.4" sequenceAccession="NM_000263" sequenceVersion="4" change="c.410_413del" MANESelect="true">
            <Expression>NM_000263.4:c.410_413del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000254.2" sequenceAccession="NP_000254" sequenceVersion="2" change="p.Thr137fs">
            <Expression>NP_000254.2:p.Thr137fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1460796923" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000263.4(NAGLU):c.410_413del (p.Thr137fs) AND Mucopolysaccharidosis, MPS-III-B" Accession="RCV001844476" Version="1">
        <ClassifiedConditionList TraitSetID="402">
          <ClassifiedCondition DB="MedGen" ID="C0086648">Mucopolysaccharidosis, MPS-III-B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-02-08" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-12" MostRecentSubmission="2022-03-12">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16151907</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="402" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3221" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Mucopolysaccharidosis, MPS-III-B</ElementValue>
                <XRef ID="Mucopolysaccharidosis+type+IIIB/4916" DB="Genetic Alliance" />
                <XRef ID="59990008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS III B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NAGLU DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="252920" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopolysaccharidosis type IIIB (Sanfilippo B)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUCOPOLYSACCHARIDOSIS, TYPE IIIB</ElementValue>
                <XRef Type="MIM" ID="252920" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0012" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopoly-saccharidosis type 3B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sanfilippo syndrome B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">N-acetyl-alpha-d-glucosaminidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS 3B</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MPS3B</ElementValue>
                <XRef Type="MIM" ID="252920" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Mucopolysaccharidosis type III (MPS III) is a multisystem lysosomal storage disease characterized by progressive central nervous system degeneration manifest as severe intellectual disability (ID), developmental regression, and other neurologic manifestations including autism spectrum disorder (ASD), behavioral problems, and sleep disturbances. Disease onset is typically before age ten years. Disease course may be rapidly or slowly progressive; some individuals with an extremely attenuated disease course present in mid-to-late adulthood with early-onset dementia with or without a history of ID. Systemic manifestations can include musculoskeletal problems (joint stiffness, contractures, scoliosis, and hip dysplasia), hearing loss, respiratory tract and sinopulmonary infections, and cardiac disease (valvular thickening, defects in the cardiac conduction system). Neurologic decline is seen in all affected individuals; however, clinical severity varies within and among the four MPS III subtypes (defined by the enzyme involved) and even among members of the same family. Death usually occurs in the second or third decade of life secondary to neurologic regression or respiratory tract infections.</Attribute>
                <XRef ID="NBK546574" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7072" />
                <XRef ID="7072" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31536183</ID>
                <ID Source="BookShelf">NBK546574</ID>
              </Citation>
              <XRef ID="79270" DB="Orphanet" />
              <XRef ID="C0086648" DB="MedGen" />
              <XRef ID="MONDO:0009656" DB="MONDO" />
              <XRef Type="MIM" ID="252920" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4114832" SubmissionDate="2022-03-11" DateLastUpdated="2022-03-12" DateCreated="2022-03-12">
        <ClinVarSubmissionID localKey="NM_000263.3:c.410_413delCGCA|MedGen:C0086648" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002103425" DateUpdated="2022-03-12" DateCreated="2022-03-12" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16151907</ID>
          </Citation>
          <Comment>Variant summary: NAGLU c.410_413delCGCA (p.Thr137LysfsX17) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 251458 control chromosomes. c.410_413delCGCA has been reported in the literature as a compound heterozygous genotype or with a second allele not specified in at-least two individuals from families affected with Mucopolysaccharidosis Type IIIB (Sanfilippo Syndrome B) (example, Beesley_2005). To our knowledge, no variant specific experimental evidence demonstrating an impact on protein function has been reported although the reported patients with this variant displayed classic features of disease confirmed by quantitative analysis of urinary glycosaminoglycan (GAGs) and enzyme assay for NAGLU (alpha-N-acetylglucosaminidase) (example, Beesley_2005). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NAGLU" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000263.3:c.410_413delCGCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0086648" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11183486</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4114832" TraitType="Disease" MappingType="XRef" MappingValue="C0086648" MappingRef="MedGen">
        <MedGen CUI="C0086648" Name="Mucopolysaccharidosis, MPS-III-B" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

